ALZHEON, INC.
Profile
Company Names
ALZHEON, INC.
Addresses
111 SPEEN STREET, SUITE 306, FRAMINGHAM, MA 01701
394 LOWELL STREET, SUITE 9, LEXINGTON, MA 02420
11 BLOSSOM CIRCLE, NATICK, MA 01760
Phone Numbers
650-392-9186
857-214-7242
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2013
State Incorporated:
DELAWARE
Total Amount Raised:
$172,460,887.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2024-02-27
$126,259,938.00
$150,000,000.00
$23,740,062.00
Equity
8
2022-12-27
$1,703,768.00
$50,004,201.00
$48,300,433.00
Equity
7
2020-09-16
$2,432,016.00
$50,000,004.00
$47,567,988.00
Equity
6
2019-04-25
$6,163,716.00
$6,163,716.00
$0.00
Equity
5
2017-05-25
$19,801,820.00
$19,801,820.00
$0.00
Equity
4
2016-02-04
$1,300,000.00
$5,000,000.00
$3,700,000.00
Debt
3
2015-07-13
$6,905,000.00
$6,905,000.00
$0.00
Debt
2
2014-12-30
$7,344,629.00
INDEFINITE
INDEFINITE
Equity
1
2013-07-23
$550,000.00
$550,000.00
$0.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
ACETI
EXECUTIVE OFFICER
FRANKLIN
BERGER
DIRECTOR
FIVE PRIME THERAPEUTICS INC
| ITHERX PHARMA, INC.
| IMMUNE DESIGN CORP.
| ALZHEON, INC.
| ATRECA, INC.
| ESSA PHARMA INC.
| CERUS ENDOVASCULAR LTD
| KEZAR LIFE SCIENCES, INC.
| BELLUS HEALTH INC.
| APPLIED THERAPEUTICS INC.
| ATEA PHARMACEUTICALS, INC.
| RAIN THERAPEUTICS INC.
| WALKING FISH THERAPEUTICS, INC.
| SATELLOS BIOSCIENCE INC.
CHRISTOPHER
NOEL
DUNN
DIRECTOR
FRANZ
HEFTI
DIRECTOR
DENNIS
LANGER
DIRECTOR
DICERNA PHARMACEUTICALS INC
| LIGHT SCIENCES ONCOLOGY INC
| INNOCOLL HOLDINGS, INC.
| SANCILIO + COMPANY, INC.
| ALZHEON, INC.
| SANCILIO PHARMACEUTICALS COMPANY, INC.
| MYRIAD GENETICS INC
| QUOIN PHARMACEUTICALS, INC.
| NEXEOS DIAGNOSTICS, INC.
| BROOKLYN IMMUNOTHERAPEUTICS, INC.
| QUOIN PHARMACEUTICALS, LTD.
| AVICENNA BIOSCIENCES, INC.
| EMPIRICO INC.
SCOTT
MINICK
DIRECTOR
GINO
SANTINI
DIRECTOR
MUNEER
SATTER
DIRECTOR
ROBERT
SILVERMAN
EXECUTIVE OFFICER
JEAN-PIERRE
SOMMADOSSI
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-02-27
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-02-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-02-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-12-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-09-16
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-04-25
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-05-25

